DA-029 2 (Abilify MyCite 2 mg)
Generic Name: aripiprazole
Pill with imprint DA-029 2 is Green, Rectangle and has been identified as Abilify mycite 2 mg. It is supplied by Otsuka Pharmaceutical Co., Ltd.
Abilify MyCite is used in the treatment of bipolar disorder; depression; schizophrenia and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Abilify MyCite 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for DA-029 2
Abilify mycite
- Generic Name:
- aripiprazole
- Imprint:
- DA-029 2
- Strength:
- 2 mg
- Color:
- Green
- Shape:
- Rectangle
- Availability:
- Prescription only
- Drug Class:
- Atypical antipsychotics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Otsuka Pharmaceutical Co., Ltd
- National Drug Code (NDC):
- 59148-0029
More about Abilify MyCite (aripiprazole)
- Abilify MyCite Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- Support Group
- 0 Reviews
- Drug class: atypical antipsychotics
Consumer resources
Other brands: Aristada, Abilify Discmelt
Professional resources
Other Formulations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
